Monitoring of Allergic and Asthmatic Symptoms in Patients Taking Dietary Supplements Joalis Bambi Bronchi and Joalis Bambi Analerg

DSC Services

Status: Unknown

Conditions: Children

Treatments: Dietary Supplement: Joalis Bambi Bronchi; Dietary Supplement: Placebo; Dietary Supplement: Joalis Bambi Analerg

Study type: Interventional

Funder types: Industry

Identifiers

NCT01684137

KS-2011-05-JOALIS

Details and patient eligibility

About

Reduction of the total IgE antibody, improved vital capacity and lung volume measured by spirometry.

Improving quality of life observed in the visual analogue scale (VAS).

Enrollment: 100 estimated patients

Sex: All

Ages: 9 to 18 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• subjects with confirmed Asthma bronchiale I-III. degrees in possible combination with other allergic symptoms treating with classic pharmacological treatment
• 9-18 years
• signed Infromed Conset

Exclusion criteria

• subjects who have previously used a food suplemts Joalis
• subjects with known intolerance or hypersensitivity to the components of food supplements
• subjects with alcohol abuse or drugs at the time of recruitment into the study
• subjects enrolled in another clinical trial in the last 1 month before enrollment in this study
• subjects in a situation which in the opinion of a doctor may interfere with optimal participation in the study or can pose a risk to the subjects
• pregnant girls, lactating girls and girls of childbearing age without adequate contraception

Trial design

100 participants in 2 patient groups, including a placebo group

Joalis Bambi Bronchi & Joalis Bambi Analerg

Active Comparator group

Description:

10 days, 2 times per day 2,5/5 ml

Treatment:

Dietary Supplement: Joalis Bambi Analerg

Dietary Supplement: Joalis Bambi Bronchi

Placebo & Placebo

Placebo Comparator group

Description:

10 days, 2 times per day 2,5/5 ml

Treatment:

Dietary Supplement: Placebo

Dietary Supplement: Placebo